Skip to main content

Blog

Save the Date for PPMD’s Upcoming Events!

...

Capricor & Nippon Shinyaku Enter Partnership for Commercialization and Distribution of CAP-1002 in the U.S.

...

Thanking PPMD’s Kathi Kinnett for 20+ Years of Service to the Duchenne Community as She Retires

...

PPMD’s Adult Advisory Committee (PAAC) in Action! 2021 Highlights & Looking Ahead

...

Dyne Therapeutics Announces FDA Clinical Hold on IND Application for DYNE-251 in Duchenne

...

Solid Provides Updates on IGNITE DMD Study and SGT-003 Pre-Clinical Data

...

Sarepta Announces Topline Results from Part 2 of Study SRP-9001-102 Evaluating Duchenne Gene Therapy Candidate

...

REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202 Gene Therapy Candidate for Duchenne

...

Edgewise Therapeutics Announces Positive Topline Results From EDG-5506 Phase 1b Trial in Adults With Becker

...

Sarepta Therapeutics Shares MOMENTUM, Study SRP-5051-201, Update

...